Advanced search
Publication Cover
Acta Orthopaedica Volume 83, 2012 - Issue 4
Journal homepage
5,159
Views
7
CrossRef citations to date
0
Altmetric
Hip

Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement

Jasvinder A SinghMedicine Service and Center for Surgical Medical Acute Care Research and Transitions (C-SMART), Birmingham VA Medical Center, Birmingham, AL;Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, University of Alabama, Birmingham, AL;Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.Correspondence[email protected]
&
David G LewallenDepartment of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
Pages 353-359 | Received 03 Nov 2011, Accepted 20 Mar 2012, Published online: 20 Aug 2012

  • Alden KJ, Duncan WH, Trousdale RT, Pagnano MW, Haidukewych GJ. Intraoperative fracture during primary total knee arthroplasty. Clin Orthop 2010;468(1):90–5.
  • Berry DJ, Kessler M, Morrey BF. Maintaining a hip registry for 25 years. Mayo Clinic experience. Clin Orthop 1997; (344): 61–8.
  • Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg (Am) 2005; 87 (3):570–6.
  • Broussard DL, Magnus JH. Coronary heart disease risk and bone mineral density among U.S. women and men. J Womens Health (Larchmt) 2008; 17 (3):479–90.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987a; 40 (5):373–83.
  • Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG, Jr. Morbidity during hospitalization: can we predict it? J Chronic Dis 1987b; 40 (7):705–12.
  • Gjertsen JE, Lie SA, Fevang JM, Havelin LI, Engesaeter LB, Vinje T, Total hip replacement after femoral neck fractures in elderly patients: results of 8,577 fractures reported to the Norwegian Arthroplasty Register. Acta Orthop 2007; 78 (4):491–7.
  • Laine L. Proton pump inhibitors and bone fractures? Am J Gastroenterol (Suppl 2) 2009; 104: S21–6.
  • Lewallen DG, Berry DJ. Periprosthetic fracture of the femur after total hip arthroplasty: treatment and results to date. Instr Course Lect 1998; 47: 243–9.
  • Lindahl H, Malchau H, Herberts P, Garellick G. Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register. J Arthroplasty 2005; 20 (7):857–65.
  • Lindahl H, Garellick G, Regner H, Herberts P, Malchau H. Three hundred and twenty-one periprosthetic femoral fractures. J Bone Joint Surg (Am) 2006; 88 (6):1215–22.
  • Lindahl H, Oden A, Garellick G, Malchau H. The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register. Bone 2007; 40 (5):1294–8.
  • Lombardi AV, Jr., Berend KR, Mallory TH, Adams JB. Modular calcar replacement prosthesis with strengthened taper junction in total hip arthroplasty. Surg Technol Int 2007; 16: 206–9.
  • Lubbeke A, Katz JN, Perneger TV, Hoffmeyer P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J Rheumatol 2007; 34 (2):394–400.
  • Malkani AL, Ong KL, Lau E, Kurtz SM, Justice BJ, Manley MT. Early- and late-term dislocation risk after primary hip arthroplasty in the Medicare population. J Arthroplasty (Suppl 6) 2010; 25: 21–5.
  • Ortiguera C 6 J , Berry D 6 J. Patellar fracture after total knee arthroplasty. J Bone Joint Surg (Am) 2002; 84 (4):532–40.
  • Pap G, Neumann HW. Periprosthetic fractures in patients with rheumatoid arthritis. Z Rheumatol 2007; 66 (1):20, 2–7.
  • Parvizi J, Ereth MH, Lewallen DG. Thirty-day mortality following hip arthroplasty for acute fracture. J Bone Joint Surg (Am) 2004; 86 (9):1983–8.
  • Peterson CA, Lewallen DG. Periprosthetic fracture of the acetabulum after total hip arthroplasty. J Bone Joint Surg (Am) 1996; 78 (8):1206–13.
  • Richards JB, Goltzman D. Proton pump inhibitors: balancing the benefits and potential fracture risks. CMAJ 2008; 179 (4):306–7.
  • Sarvilinna R, Huhtala HS, Sovelius RT, Halonen PJ, Nevalainen JK, Pajamaki KJ. Factors predisposing to periprosthetic fracture after hip arthroplasty: a case (n = 31)-control study. Acta Orthop Scand 2004; 75 (1):16–20.
  • Shah AN, Vail TP, Taylor D, Pietrobon R. Comorbid illness affects hospital costs related to hip arthroplasty: quantification of health status and implications for fair reimbursement and surgeon comparisons. J Arthroplasty 2004; 19 (6):700–5.
  • Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Cardiovascular diseases and risk of hip fracture. JAMA 2009; 302 (15):1666–73.
  • Singh JA, Sloan J. Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty. Clin Rheumatol 2009; 28 (9):1025–33.
  • Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop 2008;46611):2717–23.
  • Singh JA, Lewallen DG. Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty. Arthritis Care Res (Hoboken) 2011; 63 (10):1471–6.
  • Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop 2010;4689):2363–71.
  • Sosa M, Saavedra P, Mosquera J, Perez-Cano R, Olmos J, Munoz-Torres M, Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Aging Clin Exp Res 2011; 23 (2):112–7.
  • Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008; 179 (4):319–26.
  • Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K. Use of diuretics and risk of implant failure after primary total hip arthroplasty: a nationwide population-based study. Bone 2009; 45 (3):499–504.
  • Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Soballe K. The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case-control study. J Bone Joint Surg (Am) 2010; 92 (5):1063–72.
  • Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 2006; 79 (2):76–83.
  • Wu CC, Au MK, Wu SS, Lin LC. Risk factors for postoperative femoral fracture in cementless hip arthroplasty. J Formos Med Assoc 1999; 98 (3):190–4.
  • Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296 (24):2947–53.
  • Young SW, Walker CG, Pitto RP. Functional outcome of femoral peri prosthetic fracture and revision hip arthroplasty: a matched-pair study from the New Zealand Registry. Acta Orthop 2008; 79 (4):483–8.
  • Zuurmond RG, Pilot P, Verburg AD. Retrograde bridging nailing of periprosthetic femoral fractures. Injury 2007; 38 (8):958–64.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.